Standard Biotools (LAB) Assets Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.93% |
| Dec 31, 2025 | 11.82% |
| Sep 30, 2025 | 10.81% |
| Jun 30, 2025 | 14.55% |
| Mar 31, 2025 | 14.84% |
| Dec 31, 2024 | 18.25% |
| Sep 30, 2024 | 20.40% |
| Jun 30, 2024 | 20.09% |
| Mar 31, 2024 | 21.69% |
| Dec 31, 2023 | 1.25% |
| Sep 30, 2023 | 6.10% |
| Jun 30, 2023 | 6.55% |
| Mar 31, 2023 | 6.62% |
| Dec 31, 2022 | 6.32% |
| Sep 30, 2022 | 7.28% |
| Jun 30, 2022 | 9.62% |
| Mar 31, 2022 | -1.45% |
| Dec 31, 2021 | -2.12% |
| Sep 30, 2021 | -2.51% |
| Jun 30, 2021 | -3.29% |
| Mar 31, 2021 | -2.95% |
| Dec 31, 2020 | -2.58% |
| Sep 30, 2020 | -3.12% |
| Jun 30, 2020 | -6.21% |
| Mar 31, 2020 | -5.98% |
| Dec 31, 2019 | -8.26% |
| Sep 30, 2019 | -8.07% |
| Jun 30, 2019 | -7.44% |
| Mar 31, 2019 | -7.25% |
| Dec 31, 2018 | 21.03% |
| Sep 30, 2018 | 17.17% |
| Jun 30, 2018 | 18.27% |
| Mar 31, 2018 | 18.95% |
| Dec 31, 2017 | 20.37% |
| Sep 30, 2017 | 20.05% |
| Jun 30, 2017 | 33.83% |
| Mar 31, 2017 | 32.85% |
| Dec 31, 2016 | 31.03% |
| Sep 30, 2016 | 31.14% |
| Jun 30, 2016 | 31.91% |
| Dec 31, 2015 | 71.70% |